Recurrent Squamous Cell Carcinoma of the Hypopharynx Completed Phase 1 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0029504 (Recurrent Squamous Cell Carcinoma of the Hypopharynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02035527Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTreatment